Core Viewpoint - Crystal Tech Holdings (02228) has successfully developed and validated two innovative topical active ingredients for hair loss prevention and growth, leveraging its industry-leading AI molecular discovery platform [1] Group 1: Product Development - The two active ingredients, small molecule Remeanagen™ (XTP-118) and peptide AquaKine™ (XTP-016), have shown significant improvements in hair growth and anti-hair loss efficacy, safety, and onset speed compared to existing products [1] - Both molecules have successfully passed the INCI (International Nomenclature of Cosmetic Ingredients) registration in the United States [1] - The combined formulation product, Groland, has received cosmetic registration from the FDA (Food and Drug Administration), marking a significant entry into the consumer health sector [1] Group 2: Strategic Vision - Crystal Tech's new mission statement emphasizes the integration of AI into every new drug and the incorporation of AI molecules into enhancing everyday life [1] - The company aims to tackle major diseases through drug development while also creating consumer-grade molecular products to improve the quality of life for the general public [1]

Core Insights - Jingtai Holdings (02228) has successfully developed and validated two innovative topical active ingredients for hair growth and anti-hair loss: small molecule Remeanagen (XTP-118) and peptide AquaKine (XTP-016) [1] - The combination formula of these two molecules has shown significant superiority in hair growth and anti-hair loss effects, safety, and onset speed compared to existing similar products through rigorous human trials [1] - Both molecules have successfully passed the INCI (International Nomenclature of Cosmetic Ingredients) registration in the United States, and the combination product Groland has received FDA (Food and Drug Administration) cosmetic filing, marking Jingtai's entry into the promising consumer health sector [1] - Jingtai aims to tackle major diseases through drug development while also creating consumer-grade molecular products to enhance the quality of daily life [1] - The new mission statement of Jingtai emphasizes the integration of AI into every new drug and the incorporation of AI molecules into everyone's quality of life [1] Company Developments - The AI molecular discovery platform of Jingtai is focused on developing innovative drug molecules that save lives and creating safe and effective consumer product molecules [1] - The successful validation of the dual active ingredients positions Jingtai as a leader in the consumer health market, leveraging its AI capabilities [1]